Seres Therapeutics Statistics
Total Valuation
MCRB has a market cap or net worth of $74.95 million. The enterprise value is $125.62 million.
| Market Cap | 74.95M |
| Enterprise Value | 125.62M |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MCRB has 9.68 million shares outstanding. The number of shares has increased by 11.78% in one year.
| Current Share Class | 9.68M |
| Shares Outstanding | 9.68M |
| Shares Change (YoY) | +11.78% |
| Shares Change (QoQ) | +3.82% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 10.64% |
| Float | 8.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 65.35 |
| Forward PS | 5.91 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 2.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 109.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 3.04.
| Current Ratio | 1.65 |
| Quick Ratio | 1.55 |
| Debt / Equity | 3.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -121.87% and return on invested capital (ROIC) is -44.35%.
| Return on Equity (ROE) | -121.87% |
| Return on Assets (ROA) | -38.88% |
| Return on Invested Capital (ROIC) | -44.35% |
| Return on Capital Employed (ROCE) | -89.18% |
| Weighted Average Cost of Capital (WACC) | 2.30% |
| Revenue Per Employee | $17,379 |
| Profits Per Employee | -$710,591 |
| Employee Count | 66 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.70% in the last 52 weeks. The beta is 0.10, so MCRB's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -27.70% |
| 50-Day Moving Average | 7.30 |
| 200-Day Moving Average | 12.59 |
| Relative Strength Index (RSI) | 59.54 |
| Average Volume (20 Days) | 124,574 |
Short Selling Information
The latest short interest is 219,815, so 2.27% of the outstanding shares have been sold short.
| Short Interest | 219,815 |
| Short Previous Month | 478,817 |
| Short % of Shares Out | 2.27% |
| Short % of Float | 2.59% |
| Short Ratio (days to cover) | 3.22 |
Income Statement
In the last 12 months, MCRB had revenue of $1.15 million and -$46.90 million in losses. Loss per share was -$5.17.
| Revenue | 1.15M |
| Gross Profit | -52.30M |
| Operating Income | -87.64M |
| Pretax Income | -46.90M |
| Net Income | -46.90M |
| EBITDA | -83.80M |
| EBIT | -87.64M |
| Loss Per Share | -$5.17 |
Balance Sheet
The company has $29.83 million in cash and $80.50 million in debt, with a net cash position of -$50.67 million or -$5.23 per share.
| Cash & Cash Equivalents | 29.83M |
| Total Debt | 80.50M |
| Net Cash | -50.67M |
| Net Cash Per Share | -$5.23 |
| Equity (Book Value) | 26.50M |
| Book Value Per Share | 2.76 |
| Working Capital | 12.49M |
Cash Flow
In the last 12 months, operating cash flow was -$42.15 million and capital expenditures -$218,000, giving a free cash flow of -$42.37 million.
| Operating Cash Flow | -42.15M |
| Capital Expenditures | -218,000 |
| Depreciation & Amortization | 3.84M |
| Net Borrowing | n/a |
| Free Cash Flow | -42.37M |
| FCF Per Share | -$4.38 |
Margins
| Gross Margin | n/a |
| Operating Margin | -7,640.98% |
| Pretax Margin | -4,088.84% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MCRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.78% |
| Shareholder Yield | n/a |
| Earnings Yield | -62.57% |
| FCF Yield | -56.53% |
Analyst Forecast
The average price target for MCRB is $17.00, which is 119.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 119.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -23.16% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 22, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
MCRB has an Altman Z-Score of -13.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.34 |
| Piotroski F-Score | 1 |